168 results on '"Hormone de croissance"'
Search Results
2. L'acromégalie chez le chat : une cause fréquente de diabète sucré ?
- Author
-
Pichard, Diane and Benchekroun, Ghita
- Abstract
Copyright of Nouveau Praticien Vétérinaire Canine & Féline is the property of EDP Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
3. Effectiveness of growth hormone in promoting endometrial growth in patients with endometrial dysplasia in frozen embryo transfer.
- Author
-
Yong Wu, Yuan Tian, Lili Zhang, Li Zeng, Ying Wang, Ruifeng Shao, and Chihua He
- Subjects
HORMONE therapy ,ULTRASONIC imaging ,WOMEN ,ESTROGEN ,HEALTH outcome assessment ,HUMAN growth hormone ,EMBRYO transfer ,PREGNANCY outcomes ,RANDOMIZED controlled trials ,T-test (Statistics) ,COMPARATIVE studies ,BLOOD circulation ,ASPIRIN ,DESCRIPTIVE statistics ,RESEARCH funding ,STATISTICAL sampling ,DATA analysis software ,ENDOMETRIUM ,SUBCUTANEOUS injections - Abstract
Copyright of African Journal of Reproductive Health is the property of Women's Health & Action Research Centre and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
4. L'acromégalie est associée à des déformations vertébrales mais pas à des fractures vertébrales : étude monocentrique transversale.
- Author
-
Plard, Charlotte, Hochman, Clarisse, Hadjadj, Samy, Le Goff, Benoît, Maugars, Yves, Cariou, Bertrand, Drui, Delphine, and Guillot, Pascale
- Abstract
• Les patients atteints d'acromégalie ont une faible prévalence de fractures vertébrales. • Étude des anomalies qualitatives de la colonne vertébrale chez les patients acromégaux. • Le patient acromégalie avait une forte prévalence de déformations de la colonne vertébrale. La plupart des études retrouvent une majoration du risque de fractures vertébrales chez les patients acromégales, malgré une densité minérale osseuse normale. Nous avons étudié la prévalence des fractures vertébrales chez les patients acromégales de moins de 80 ans suivis au CHU de Nantes. Étude transversale monocentrique réalisée au CHU de Nantes de 1988 à 2018. Cinquante patients (18 femmes, 32 hommes) d'un âge médian de 52,3 ans (27 -78 ans) ont été inclus. Les fractures vertébrales étaient évaluées sur des radiographies conventionnelles des rachis lombaire et thoracique de face et de profil, selon la méthode semi-quantitative de Genant. Nous avons également étudié les déformations vertébrales autres que les fractures, en utilisant 3 critères : présence d'ostéophytes, présence de pincement discal et aspect cunéiforme des vertèbres. Nous avons analysé la densité minérale osseuse par absorptiométrie bi-photonique et le statut hormonal. Trois patients (6 %) présentaient une fracture vertébrale : une fracture de grade 1 et 2 fractures de grade 2 selon la classification de Genant, chez deux patients ostéoporotiques et un patient ostéopénique. Leurs déficits anté-hypophysaires étaient substitués. En considérant les déformations franches (ostéophyte ou pincement discal ≥ grade 2 ou aspect cunéiforme), le rachis dorsal était déformé chez 22 patients (44 %) et le rachis lombaire chez 21 patients (42 %). Les patients acromégales présentaient une faible prévalence de fractures vertébrales, mais un nombre important de déformations vertébrales. Nous supposons que cette forte prévalence de déformations franches pourrait expliquer la forte prévalence de fractures vertébrales rapportée précédemment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. La transition chez l'enfant ayant un déficit en hormone de croissance - Point de vue d'une association de patients.
- Author
-
Vankemmel, Romain, Barasz, Salomé, and Demaret, Béatrice
- Subjects
- *
SOMATOTROPIN , *HORMONE therapy , *THERAPEUTICS , *CHRONIC diseases , *PITUITARY hormones - Abstract
For twenty years, growth hormone therapy has been available for adults with growth hormone deficiency. Recommendations and multiple tools have been put in place in order to best accompany the transition period, which is the obligatory passage for children with a chronic disease from pediatric care to the adult sector. Nevertheless, the fact remains that many adults are not treated or even monitored for their growth hormone deficiency, which is not without consequences for their state of health. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. The effect of miR-6523a on growth hormone secretion in pituitary cells of Yanbian yellow cattle.
- Author
-
Jiuxiu Ji, Taihua Jin, Rui Zhang, Angang Lou, Yingying Chen, Siyu Xiang, Changyan Cui, Longzheng Yu, and Lizeng Guan
- Subjects
SOMATOTROPIN ,SOMATOSTATIN receptors ,CATTLE breeds ,CATTLE ,ANIMAL development ,MESSENGER RNA ,PITUITARY gland ,PITUITARY dwarfism - Abstract
Copyright of Canadian Journal of Animal Science is the property of Canadian Science Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2020
- Full Text
- View/download PDF
7. Utilisation des facteurs de croissance dans les maladies hépatiques.
- Author
-
Pureur, Dimitri, Merlen, Gregory, Weil-Verhoeven, Delphine, Cervoni, Jean-Paul, Di Martino, Vincent, Tordjman, Thierry, and Thévenot, Thierry
- Abstract
Résumé: Les maladies chroniques du foie sont responsables d'une morbi-mortalité élevée. Après une agression hépatocellulaire, les hépatocytes matures peuvent proliférer et réparer le foie endommagé, mais ce processus de régénération est souvent limité. Lorsque la prolifération des hépatocytes est compromise, des cellules hépatiques progénitrices peuvent se différencier en hépatocytes. La transplantation hépatique représente le traitement de choix des patients ayant une insuffisance hépatique sévère mais n'est pas toujours possible en raison de la pénurie de greffons. La thérapie cellulaire, qui pourrait pallier cet écueil, repose sur l'inoculation de cellules souches de la moelle osseuse (CSMO) ou sur l'utilisation du facteur de croissance de la lignée granulocytaire (G-CSF) afin de mobiliser les CSMO et leur permettre de se différencier en hépatocytes fonctionnels. Les principales utilisations du G-CSF en hépatologie sont faites actuellement dans le cadre d'essai thérapeutique au cours de l'hépatite alcoolique aiguë sévère, de la cirrhose décompensée sans ou avec défaillance d'organes. Les résultats obtenus avec le G-CSF dans ces trois indications, sur la survie et sur l'amélioration des scores hépatiques, semblent prometteurs. Cependant, ces études majoritairement indiennes, sont d'effectif limité ; de plus, les résultats intérimaires d'une étude allemande récente réalisée chez des patients en ACLF n'ont pas confirmé l'innocuité du G-CSF dans cette indication et la survie n'était pas améliorée. De nombreuses études en cours ou en devenir et incluant des effectifs plus larges devraient permettre de confirmer ou non l'intérêt du G-CSF dans les maladies hépatiques sévères. Chronic liver diseases are responsible for a high worldwide morbidity and mortality. Following hepatocellular injury, the remaining mature hepatocytes may proliferate and repair the damaged liver, but this regenerative process is often limited. When hepatocyte proliferation is compromised, hepatic progenitor cells may proliferate and differentiate into hepatocytes. Liver transplantation (LT) represents the only proven definitive treatment for patients with end-stage liver disease but LT is not always possible because of the scarcity of donor organs. Stem cell therapy, which could overcome this pitfall, is based on two strategies: The first one consists on the inoculation of bone marrow-derived stem cells (BMSC) and the second one uses granulocyte colony-stimulating factor (G-CSF) which mobilizes BMSC. G-CSF is currently used in hepatology, as part of therapeutic trials, in three different contexts, namely severe acute alcoholic hepatitis, decompensated cirrhosis and cirrhosis with organ failure. With G-CSF, the results on survival and on liver specific scores in these three indications appear promising. However, these trials are mostly Indian and sample sizes are small; in addition, interim results from a recent German study did not confirm the safety of G-CSF in ACLF patients and survival was not improved. Several studies using G-CSF in hepatology are currently in progress and will be able to confirm (or not) the relevance of G-CSF in severe liver disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. Ghrelin is not altered after acute exercises at different intensities in overweight middle-aged individuals.
- Author
-
Ouerghi, N., Brini, S., Zaouali, M., Feki, M., Tabka, Z., and Bouassida, A.
- Subjects
- *
GHRELIN , *OBESITY , *SOMATOTROPIN , *SOMATOMEDIN C , *EXERCISE - Abstract
The purpose of this study was to investigate the effect of acute moderate (MEx) and heavy (HEx) exercises on ghrelin, growth hormone (GH), insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in untrained subjects. A pre/post interventional study including seven overweight middle-aged males (mean ± SD: age = 36.4 ± 4.35 years) was designed. Participants performed two sessions of exercise at 7-day interval. Each session consisted in cycling exercise during 20 min at 60% (moderate exercise, MEx) or at 80% (heavy exercise, HEx) of peak aerobic power (PAP). Venous blood samples were obtained before, at the end (0 min) and after 30, 60, 90 and 120 min recovery in each session. After exercise and during recovery, ghrelin, IGF-1 and IGFBP-3 concentrations have been unchanged in both groups. However, GH concentration has significantly increased at the end of exercise (0.12 ± 0.09 vs. 1.08 ± 0.73 ng·mL−1; P = 0.004; ES = 1.99) and 30 min after (0.12 ± 0.09 vs. 0.60 ± 0.36 ng·mL−1; P = 0.035; ES = 1.98) in HEx session, only. No significant correlation was observed at baseline between ghrelin and the other markers (GH, IGF-1 and IGFBP-3). Our results suggested that 20 min moderate or heavy sub-maximal exercises not stimulate the production and the release of ghrelin after 2 hours recovery. In our experimental conditions, it appears that: ghrelin does not participate in the regulation of the GH response to exercise in overweight males and; exercise intensity and duration may be determinant to affect ghrelin secretion. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. The effect of changes in concentric-eccentric contraction time ratio on hormonal response to resistance exercise in trained men.
- Author
-
Sheikholeslami-Vatani, D., Ahmadi, S., Chehri, B., and Tadibi, V.
- Subjects
- *
ISOMETRIC exercise , *MUSCLE contraction , *SOMATOTROPIN , *TESTOSTERONE , *LEG exercises , *BENCH press , *HAMSTRING muscle - Abstract
Summary Objectives The aim of this study was to investigate the effect of changing concentric-eccentric contraction time ratio in a single session of resistance exercise on hormonal response in trained men. Methods In a double-blind cross section study design, ten young men (mean age: 26.3 ± 1.2 years, mean weight: 81.2 ± 4.25 kg, and mean height: 178 ± 6 cm) were selected and completed 4 resistance exercise sessions with 3 days’ between sessions interval. Protocols included, 1 second concentric and 1 second eccentric contraction; 3 second concentric and 3 second eccentric contraction; 4 second concentric and 2 seconds eccentric contraction; 2 seconds concentric and 4 seconds eccentric contraction. In each session subjects performed one of the four protocols. The exercise protocol was consisted of leg extension, bench press, hamstring curls and lat pull-down with three sets of eight repetitions and intensity of 0.65 of one repetition maximum. Rest times for sets and exercises were 1 and 2 minutes respectively. Blood samples were collected before and immediately after exercise. Results Increases in lactate were observed after all protocols. Serum levels of testosterone and growth hormone increased significantly in all, but 1 second concentric and 1 second eccentric contraction protocol, while level of serum cortisol did not change significantly in none of the protocols. Conclusions The result of this study showed that in a single session of RE, changes in concentric-eccentric contraction time ratio had no effect on hormonal response, however slower contractions produced greater hormonal response compare to normal protocol. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Hormones de croissance, agonistes, antagonistes et inhibiteurs.
- Author
-
Reyt, Vincent and Buxeraud, Jacques
- Abstract
Résumé Les hormones de croissance et leurs agonistes, les antagonistes de l’hormone de croissance et les inhibiteurs de la sécrétion de l’hormone de croissance appartiennent au secteur de l’endocrinologie. Leurs indications sont multiples et leur dispensation à l’officine nécessite un conseil éclairé de la part du pharmacien. Summary Growth hormones and their agonists, growth hormone receptor antagonists and growth hormone secretion inhibitors belong to the endocrinology sector. Their indications are multiple and the pharmacist must be able to provide clear advice when dispensing them. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. Salinity acclimation and advanced parr-smolt transformation in growth-hormone transgenic coho salmon ( Oncorhynchus kisutch).
- Author
-
Bystriansky, J.S., Clarke, W.C., Alonge, M.M., Judd, S.M., Schulte, P.M., and Devlin, R.H.
- Subjects
- *
SEAWATER , *SALINITY , *HORMONES , *COHO salmon , *SMOLTING - Abstract
Growth hormone (GH) is involved in the parr-smolt transformation of salmonid fishes and is known to improve salinity tolerance. This study compared the capacity for seawater acclimation of GH transgenic coho salmon ( Oncorhynchus kisutch (Walbaum, 1792)) to that of wild-type fish, allowing examination of responses to sustained (chronic) exposure to elevated GH. GH transgenic fish (GH TG) smolted 1 year in advance of wild-type salmon and showed a greater capacity to hypo-osmoregulate in seawater. As GH TG fish were much larger than the wild-type fish, a second experiment was conducted with three size-matched groups of coho salmon (a 1+-year-old wild-type group, a 1+-year-old ration-restricted GH TG group, and a 0+-year-old fully fed GH TG group). When size-matched, the effect of GH transgenesis was not as dramatic, but the feed-rationed TG1+ group exhibited smaller deviations in plasma ion and osmolality levels following seawater exposure than did the other groups, suggesting a somewhat improved hypo-osmoregulatory ability. These results support a role for GH in the development of seawater tolerance by salmonid fishes independent of fish size. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. Conduite pratique devant une anomalie de la croissance.
- Author
-
Bouhours-Nouet, N., Donzeau, A., and Coutant, R.
- Abstract
Résumé Les courbes de croissance staturopondérale et de corpulence sont les éléments essentiels pour statuer sur une éventuelle anomalie de la croissance. La croissance d’un enfant à un âge donné est dite « anormale » si elle se situe au-delà de +2 déviations standard (DS) ou en deçà de −2DS. Elle mérite également exploration en cas d’accélération ou de ralentissement excessif de la vitesse de croissance conduisant à un changement de couloir. Enfin, la notion de couloir génétique de croissance est essentielle. La petite taille est le plus souvent (> 70 % des cas) de type constitutionnel (d’hérédité polygénique). La pathologie endocrinienne représente moins de 10 % des étiologies. Le déficit en hormone de croissance peut être secondaire à une lésion (tumeur) ou à une irradiation de la région hypothalamohypophysaire, être d’origine génétique (anomalie monogénique ou syndrome), malformative (interruption de tige pituitaire avec posthypophyse ectopique, rarement de cause monogénique) ou être idiopathique (imagerie par résonance magnétique [IRM] hypothalamohypophysaire normale). Pour ce dernier, le diagnostic est difficile et souvent fait par excès. Il faut systématiquement évoquer le syndrome de Turner chez la fille et réaliser un caryotype, même en l’absence d’élément dysmorphique évocateur. Le retard de croissance intra-utérin est la cause de 10 % des petites tailles, mais il nécessite une démarche diagnostique étiologique, à la recherche d’une maladie ayant perturbé la croissance dès la période anténatale. Dans un contexte familial, la réalisation systématique de radiographies de squelette permet d’identifier des anomalies osseuses constitutionnelles caractéristiques de dyschondrostéose ou d’hypochondroplasie. La fréquence des anomalies osseuses dans les retards staturaux est mal précisée, mais on peut l’estimer à près de 5 % des cas. Le retard pubertaire est responsable d’un retard à l’accélération de la vitesse de croissance staturale. Cela explique que le motif de consultation soit souvent la petite taille. Chez le garçon, il s’agit d’un retard pubertaire simple dans plus de 80 %. Chez la fille, il est plus souvent d’origine organique. La grande taille, constitutionnelle dans plus de 90 % des cas, est un motif beaucoup plus rare de consultation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
13. Décision médicale partagée chez l’adolescent traité par hormone de croissance au long cours : focus groups interrogeant les médecins
- Author
-
Almanini, Coleen, Université de Bretagne Occidentale - UFR Médecine et Sciences de la Santé (UBO UFR MSS), Université de Brest (UBO), and Régis Coutant
- Subjects
Adhérence ,Adolescent ,[SDV]Life Sciences [q-bio] ,Décision médicale partagée ,Hormone de croissance - Abstract
Le traitement par hormone de croissance concerne des milliers de jeunes en France, atteints de pathologies diverses, entrant dans le cadre des maladies chroniques. L’adhérence chez ces patients est une des préoccupations des pédiatres, dans la mesure où cela impacte les résultats du traitement, notamment sur le gain de taille. Un facteur peu étudié dans cette population mais pressenti comme impactant l’adhérence est la décision médicale partagée, qui se définit comme une relation de soin dans laquelle le patient et le médecin collabore pour déterminer la meilleure option de traitement. L’objectif de l’étude est d’explorer la vision des médecins concernant la participation au projet de soin de l’adolescent traité par hormone de croissance au long cours.Méthode : dans cette étude qualitative exploratoire, des pédiatres spécialisés en Endocrinologie, ayant au moins 5 ans d’expérience avec les patients traités par hormone de croissance, ont été recrutés sur la base du volontariat. Des focus groups ont été menés et transcrits, puis codés au moyen d’une analyse thématique, alliant une approche déductive et inductive, par une des investigatrices et relus par un autre investigateur, ayant une expérience significative dans ce type d’analyses.Résultats : 15 pédiatres issus de 4 centres hospitalo-universitaires différents ont été interrogés lors de 3 focus groups. La motivation dans le traitement semble influencée par les bénéfices attendus et perçus par le jeune, ainsi que par les contraintes perçues du traitement. Les compétences de l’adolescent, englobant ses connaissances sur sa maladie et sur son traitement, ainsi que sa capacité d’auto normativité, vont impacter ses attentes et sa participation à son projet de soin. Les parents sont également partie prenante de ce projet, tant au moment de la décision que sur la pérennisation du traitement. Au long cours, les besoins du jeune varient, allant de la volonté de faire le point sur le traitement à la demande d’arrêt de celui-ci. Enfin, l’établissement d’une relation de confiance entre le médecin et l’adolescent, avec une écoute attentive de la part du médecin, est essentiel.Discussion : le replacement de l’adolescent dans la décision semble la clé menant à sa participation à son projet de soin. Plusieurs stratégies d’implications ont été mises en évidence (faire le point régulièrement sur l’histoire médicale et les bénéfices du traitement, implication dans le choix du dispositif d’injection, compétences relationnelles du médecin pour une meilleure écoute des besoins du jeune). Un biais cognitif est cependant probable et de futures études sont nécessaires pour recueillir la vision des adolescents et de leurs parents.Conclusion : la décision médicale partagée chez l’adolescent traité par hormone de croissance au long cours repose sur un ensemble de facteurs interconnectés (place des parents, attitude du médecin et place laissée et prise par l’adolescent dans la décision). Plusieurs stratégies d’implication de l’adolescent ont été mises en évidence, ouvrant la voie à des pistes pour l’amélioration des pratiques dans la prise en charge de ces patients.
- Published
- 2021
14. TRANSMISSION INTERHUMAINE DES PROTÉINOPATHIES DU SYSTÈME NERVEUX CENTRAL : LES DONNÉES DISPONIBLES EN 2016.
- Author
-
HAÏK, Stéphane
- Abstract
Copyright of Bulletin de l'Académie Vétérinaire de France is the property of Academie Veterinaire de France and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2017
- Full Text
- View/download PDF
15. Science and the applications of science from Louis Pasteur to Jacques Monod.
- Author
-
Schwartz, Maxime
- Subjects
- *
VACCINES , *MOLECULAR biology , *HUMAN growth hormone - Abstract
Jacques Monod's ideas on the applications of science came within the scope of a long tradition at the Institut Pasteur. Louis Pasteur, whose scientific career was characterized by a permanent come and go between science and its applications, long opposed the idea of getting any income from his research, until the financial needs of the Institut Pasteur made him change his mind. As for Jacques Monod, he remained a fervent supporter of basic science during his whole scientific career. However, once he became director of the Institut Pasteur, he realized that the applications of research had to be developed to support the institute from a financial point of view. Thus, he reorganized the valorization of research in the institute, through an incitation of scientists to develop projects with possible applications, and by creating a company, Institut Pasteur Production, for which he had a factory built, and which was in charge of producing and commercializing the vaccines and reagents stemming from the research at the Institut Pasteur. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
16. Traitement du panhypopituitarisme dans un contexte de craniopharyngiome
- Author
-
Casteleiro, Marine, Faculté de Pharmacie - Clermont-Auvergne (FP - UCA), Université Clermont Auvergne (UCA), and Marie-Ange Civiale
- Subjects
Insuffisance hypophysaire ,Craniopharyngiome ,Diabète insipide ,[SDV]Life Sciences [q-bio] ,Hypophyse ,Déficit gonadotrope ,Déficit corticotrope ,[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences ,Hormone de croissance ,Panhypopituitarisme - Abstract
Le craniopharyngiome est une tumeur épithéliale bénigne prenant naissance dans le cerveau, plus précisément au niveau de l’hypophyse ou de la tige pituitaire. Cette maladie bien que rare, affecte une personne sur cinquante mille. Elle peut être découverte à n’importe quel âge de la vie puisque cette pathologie silencieuse à ses débuts, passe souvent inaperçue en raison de symptômes peu spécifiques. Il s’agit toutefois d’une maladie grave puisqu’elle peut entrainer à terme des séquelles endocriniennes, visuelles, ou neuro intellectuelles. Le craniopharyngiome nécessite une prise en charge à la fois médicale et thérapeutique. Dans un premier temps, le traitement consiste en l’exérèse la plus complète possible de la tumeur mais la proximité immédiate de l’hypophyse avec des structures essentielles en fait une chirurgie très délicate et non dénuée de risque. Outre les risques inhérents à l’opération, le retrait de la tumeur conduit à un dysfonctionnement hypothalamo-hypophysaire plus ou moins complet.
- Published
- 2021
17. Hormonal responses after resistance exercise performed with maximum and submaximum movement velocities.
- Author
-
Smilios, Ilias, Tsoukos, Panagiotis, Zafeiridis, Andreas, Spassis, Apostolos, and Tokmakidis, Savvas P.
- Subjects
- *
VERTICAL jump , *PHYSIOLOGICAL adaptation , *ANALYSIS of variance , *EXERCISE , *EXERCISE physiology , *HYDROCORTISONE , *JUMPING , *MUSCLE strength , *STATISTICS , *TESTOSTERONE , *DATA analysis , *HUMAN growth hormone , *REPEATED measures design , *DESCRIPTIVE statistics - Abstract
This study examined the effects of maximum and submaximum movement velocities after a muscular hypertrophy type resistance exercise protocol on testosterone, human growth hormone (hGH) and cortisol concentrations and on neuromuscular performance assessed with a vertical jump. Eleven males performed a control and 3 resistance exercise protocols (4 sets of squat and 4 sets of leg-press exercises, 8 repetitions/set, 10-repetition maximum load). The first exercise protocol was performed at maximum velocity ( Vmax); the second at 70% of Vmax with equal training volume (70% VmaxEV) to Vmax; and the third at 70% of Vmax (70% Vmax) with a 10.6% higher training volume to Vmax. Testosterone and hGH increased after all exercise protocols ( p < 0.05) compared with baseline and were higher versus control values ( p < 0.05). Cortisol concentrations gradually decreased in 70% Vmax, 70% VmaxEV and control protocols following a typical circadian rhythm ( p < 0.05), but remained relatively constant in Vmax protocol. Comparisons among protocols showed that hGH was higher in 70% Vmax versus Vmax ( p < 0.05), while cortisol was higher in Vmax versus 70% VmaxEV and control ( p < 0.05). The greatest reduction in vertical jump and increase in heart rate were observed after the Vmax protocol ( p < 0.05). In conclusion, a hypertrophy type resistance exercise protocol performed at maximum movement velocity increases testosterone and hGH and generates a greater biological stress, as evident by a higher cortisol concentrations and heart rate responses, and a greater reduction in neuromuscular performance. A protocol, however, performed at submaximum movement velocity combined with greater training volume stimulates to a greater extent the hGH response with no effect on cortisol. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
18. Performing resistance exercise before versus after aerobic exercise influences growth hormone secretion in type 1 diabetes.
- Author
-
Yardley, Jane E., Sigal, Ronald J., Riddell, Michael C., Perkins, Bruce A., and Kenny, Glen P.
- Subjects
- *
AEROBIC exercises , *ANALYSIS of variance , *BLOOD sugar , *EXERCISE , *EXERCISE physiology , *EXPERIMENTAL design , *TYPE 1 diabetes , *MUSCLE strength , *RESEARCH funding , *STATISTICS , *T-test (Statistics) , *DATA analysis , *HUMAN growth hormone , *REPEATED measures design , *DATA analysis software , *DESCRIPTIVE statistics - Abstract
We compared growth hormone (GH) and plasma glucose (PG) levels in type 1 diabetic individuals performing aerobic before resistance exercise (AR) to when resistance exercise was performed first (RA). In AR, GH secretion declined in late exercise while it rose throughout exercise in RA, resulting in higher GH in RA versus AR at exercise completion. Higher GH during RA may support PG by increasing hepatic glucose production and lipid mobilization. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
19. Étude de la croissance staturale de la cohorte réunionnaise de patients atteints du syndrome de Larsen de La Réunion. Analyse de la réponse et tolérance au traitement par hormone de croissance
- Author
-
Périer, Élodie, Université de La Réunion - UFR Santé (UR UFRS), Université de La Réunion (UR), and Laure Houdon Nguyen
- Subjects
Linkeropathy ,Dysplasie squelettique rare ,Linkéropathies ,[SDV]Life Sciences [q-bio] ,Puberty ,Puberté ,Larsen de La Réunion ,Rare skeletal dysplasia ,Larsen syndrome of Reunion Island ,Hormone de croissance ,Growth hormone ,Croissance staturale - Abstract
Introduction: Larsen syndrome of Reunion Island is a rare skeletal dysplasia. Patients suffer from facial dysmorphia, articular dislocations and a severe retarded physical development. It is caused by a homozygous mutation in the ß4GALT7 gene. The growth of these patients still needs to be better understood. This study aims to analyse the physical development of Larsen syndrom patients based on the largest group possible, as well as evaluate their response and tolerance to growth hormone treatment.Method: It is an observational retrospective cohort study and monocentric on 37 patients in Reunion, from 1927 to 2020. Inclusion criteria are both clinical and genetic. Results: 37 patients were considered. The average adult size is 127.1 cm (-8 DS) +/- 10.4 (literally 114-139 [-10 to -6 DS]) and 120.6 cm (-7,5 DS) +/- 7.6 (literally 110-134.5 [-9.5 à -5 DS]) respectively, for men (n=4) and women (n=8). With hormone growth treatment, the average adult size is 137.4 cm (-6 DS) +/- 10.1 (literally 121-146 [-9 to -4,5 DS]) and 125 cm (-7 DS) +/- 14 (literally 101-135 [-11 to -5 DS]) respectively, for men (n=5) and women (n=5). From a clinical point of view, one girl had worsened scoliosis, but also progressed after stopping growth hormone treatment. From a biological point of view, two patients have developed type 2 diabetes after stopping growth hormone treatment.Conclusion: Larsen syndrome of Reunion Island patients suffer from a severe retarded physical development, that should benefit from endocrinological exploration. Growth hormone treatment may be discussed with the child and family in order to improve adult size prognosis and body composition.; Introduction : Le Syndrome de Larsen de La Réunion est une dysplasie squelettique rare, endémique de l’île. Les patients ont une dysmorphie faciale, des luxations articulaires par hyperlaxité ligamentaire et un retard statural sévère. Il est dû à une mutation homozygote du gène ß4GALT7. La croissance de ces patients est mal connue. L’objectif de cette étude est d’analyser la croissance staturale de la plus grande cohorte de Larsen de La Réunion, ainsi que d’évaluer le traitement par hormone de croissance et la tolérance. Méthode : Il s’agit d’une étude de cohorte observationnelle, rétrospective et monocentrique sur l’île de La Réunion, de 1927 à 2020. Les critères d’inclusion sont cliniques et génétiques. Résultats : 37 patients ont été inclus. La taille moyenne adulte est de 127,1 cm (-8 DS) +/- 10,4 (114-139 soit -10 à -6 DS) et de 120,6 cm (-7,5 DS) +/- 7,6 (110-134,5 soit -9,5 à -5 DS) respectivement pour les hommes (n=4) et les femmes (n=8). Sous hormone de croissance, elle est de 137,4 cm (-6 DS) +/- 10,1 (121-146 soit -9 à -4,5 DS) et 125 cm (-7 DS) +/- 14 (101-135 soit -11 à -5 DS) respectivement pour les hommes (n=5) et les femmes (n=5). Sur le plan clinique, une fille a eu une aggravation de scoliose qui a continué à progresser après l’arrêt du traitement. Sur le plan biologique, deux ont développé un diabète de type 2 post arrêt du traitement. Conclusion : Les patients Larsen de La Réunion présentent un retard statural sévère qui doit bénéficier d’une exploration endocrinologique. Un traitement par hormone de croissance peut être discuté avec la famille et l’enfant pour améliorer le pronostic de taille finale et la composition corporelle.
- Published
- 2020
20. Les troubles de la croissance chez l’enfant : hormone de croissance et conseils associés
- Author
-
Jullian, Caroline, Aix-Marseille Université - Faculté de pharmacie (AMU PHARM), Aix Marseille Université (AMU), and Frédérique Grimaldi
- Subjects
Enfant ,[SDV]Life Sciences [q-bio] ,Petite taille ,[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences ,Hormone de croissance ,Somatropine ,Officine ,GH - Abstract
La croissance résulte d’un ensemble de phénomènes complexes sous l’influence de multiples facteurs : génétiques, métaboliques, environnementaux et surtout hormonaux. Son suivi doit être effectué de manière régulière tout au long du développement de l’enfant. On parle de retard de croissance staturale lorsque la taille de l’enfant est inférieure à moins 2 déviations standards par rapport aux courbes de croissance de référence. S’il existe également un ralentissement de la vitesse de croissance, il convient d’effectuer une exploration de ce retard, par un pédiatre endocrinologue, afin d’en rechercher la cause. Le plus souvent les examens effectués ne permettent pas d’en déterminer l’origine sauf dans certaines situations cliniques bien précises. La petite taille peut ainsi provenir d’un déficit en hormone de croissance ou être secondaire à de multiples pathologies. Un traitement par hormone de croissance recombinante peut alors être administré quotidiennement à l’enfant lorsqu’un certain nombre de critères sont remplis. L’efficacité de cette thérapeutique repose principalement sur sa régularité : l’acceptation et la compréhension par les jeunes patients et leurs parents est donc indispensable. Les ateliers d’éducation thérapeutique proposés par les services d’endocrinologie pédiatrique s’inscrivent dans cette démarche mais également le pharmacien d’officine via son rôle de conseil qu’il accomplit lors des dispensations mensuelles du traitement. En effet ces échanges réguliers sont propices à l’instauration d’un dialogue et d’une relation de confiance avec l’enfant et sa famille permettant d’appréhender l’observance du traitement et d’en éviter l’interruption.
- Published
- 2020
21. Wachstumshormon bei Kindern und Jugendlichen: Erwartungen und Realität.
- Author
-
Burckhardt, Marie-Anne and Zumsteg, Urs
- Subjects
- *
SOMATOTROPIN , *CHILDREN'S health , *ADOLESCENT health , *HORMONE therapy , *HYPOTHALAMIC-pituitary-thyroid axis , *TURNER'S syndrome , *ENDOCRINOLOGISTS , *SHORT stature - Abstract
Growth Hormone therapy has been used therapeutically for over 50 years. Until recently, growth hormone therapy has been restricted for children and adolescents with proven hypothalamic-pituitary short stature. Today some other causes - but not all - can be treated with growth hormone. To the well-established indications belong apart from proven growth hormone deficiency, children with Turner Syndrome and with Prader Willi Syndrome, children born small for gestational age without catch-up growth and children with chronic kidney disease and with some haematological and oncological diseases. Careful and accurate diagnosis is essential. Growth hormone therapy is rare in everyday practice and requires close cooperation with a pediatrie endocrinologist. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
22. Expression of genes involved in key metabolic processes during winter flounder ( Pseudopleuronectes americanus) metamorphosis.
- Author
-
Vagner, Marie, de Montgolfier, Benjamin, Sévigny, Jean-Marie, Tremblay, Réjean, and Audet, Céline
- Subjects
- *
METAMORPHOSIS , *SOMATOTROPIN , *ANTIOXIDANTS , *ENERGY metabolism , *WINTER flounder - Abstract
The aim of this study was to better understand the molecular events governing ontogeny in winter flounder ( Pseudopleuronectes americanus (Walbaum, 1792)). The expression of seven genes involved in key metabolic processes during metamorphosis were measured at settlement (S0), at 15 (S15), and 30 (S30) days after settlement and compared with those in pelagic larvae prior to settlement (PL). Two critical stages were identified: (1) larval transit from the pelagic to the benthic habitat (from PL to S0) and (2) metamorphosis maturation, when the larvae stay settled without growth (from S0 to S30). Growth hormone ( gh) gene expression significantly increased at S0. At S30, an increase in cytochrome oxidase ( cox) gene expression occurred with a second surge of gh gene expression, suggesting that enhanced aerobic capacity was supporting growth before the temperature decrease in the fall. Expression patterns of pyruvate kinase ( pk), glucose-6-phosphate dehydrogenase ( g6pd), and bile salt activated lipase ( bal) genes indicated that energy synthesis may be mainly supplied through glycolysis in PL, through the pentose-phosphate pathway at settlement, and through lipid metabolism at S30. The expression of the heat-shock protein 70 ( hsp70), superoxide dismutase ( sod), cox, and peroxiredoxin-6 ( prx6) genes revealed that oxidative stress and the consequent development of antioxidative protection were limited during the PL stage, reinforced at settlement, and very high at S30, certainly owing to the higher growth rate observed at this period. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
23. Influence of upper-body exercise order on hormonal responses in trained men.
- Author
-
Simão, Roberto, Leite, Richard Diego, Speretta, Guilherme Fleury Fina, Maior, Alex Souto, De Salles, Belmiro Freitas, De Souza Junior, Tácito Pessoa, Vingren, Jakob L., and Willardson, Jeffrey M.
- Subjects
- *
ANALYSIS of variance , *EXERCISE , *EXPERIMENTAL design , *FISHER exact test , *HORMONES , *MUSCLE strength , *STATISTICS , *T-test (Statistics) , *ARM exercises , *DATA analysis , *PRE-tests & post-tests , *INTER-observer reliability , *REPEATED measures design , *RESEARCH methodology evaluation , *DATA analysis software , *STATISTICAL models , *DESCRIPTIVE statistics - Abstract
The aim of this study was to examine acute hormonal responses after different sequences of an upper-body resistance-exercise session. Twenty men completed 2 sessions (3 sets; 70% 1-repetition maximum; 2 min passive rest between sets) of the same exercises in opposite sequences (larger to smaller vs. smaller to larger muscle-group exercises). Total testosterone (TT), free testosterone (FT), testosterone/cortisol (T/C) ratio, sex-hormone-binding globulin (SHBG), growth hormone (GH), and cortisol (C) concentrations were measured before and immediately after each sequence. The results indicate that the GH concentration increased after both sessions, but the increase was significantly greater ( p < 0.05) after the sequence in which larger muscle-group exercises were performed prior to the smaller muscle-group exercises. No differences were observed between sessions for TT, FT, SHBG, C, or the T/C ratio at baseline or immediately after resistance exercise. These results indicate that performing larger muscle-group exercises first in an upper-body resistance-exercise session leads to a significantly greater GH response. This may have been due to the significantly greater exercise volume accomplished. In summary, the findings of this investigation support the common prescriptive recommendation to perform larger-muscle group exercises first during a resistance-exercise session. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
24. Mobilisation des cellules souches hématopoïétiques : état de l’art en 2011 et perspectives
- Author
-
Bijou, F., Ivanovic, Z., Boiron, J.-M., and Nicolini, F.
- Subjects
- *
BIOTECHNOLOGY , *HEMATOPOIETIC stem cells , *DRUG therapy , *AUTOTRANSPLANTATION , *HOMOGRAFTS , *HEMATOPOIETIC growth factors , *GENETIC polymorphisms , *CHEMOKINES - Abstract
Abstract: High-dose chemotherapy with stem cells support has largely improved in terms of hematopoietic stem and progenitor cells harvest procedures as well as in those, which target or manipulate the cellular composition of autologous graft. Optimal preparative regimens and supportive care had lead to better use of autologous transplantation procedure. For other patients assigned to hematopoietic transplantation, availability of allogeneic donors appears to be an interesting alternative source of hematopoietic stem cells. Since three decades, hematopoietic growth factors development has allowed mobilization optimization and collection of peripheral hematopoietic stem cells leading to reduced days of hospitalization and less blood products requirements, being more cost-effective for patients in autologous transplantation settings and for stem cell collection facilities in allogeneic ones. New perspectives include, besides ex vivo manipulation of graft, development of mobilizing drugs in order to perform transplantation even in poor mobilizers patients. An important goal is achieved with the description of genetic polymorphisms related to optimal mobilization of stem cells. New approach using more promising and selective agents called chemokines, such as plerixafor the main leader among these agents are now available and appear complementary for alternative approach using cytokines alone (G-CSF, GM-CSF, SCF). The aim of this review is to assess the evolution of theses biotechnologies and their role in different steps of autologous transplantation and allogeneic stem cells collection. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
25. The acute effects of a low and high dose of oral l-arginine supplementation in young active males at rest.
- Author
-
Forbes, Scott C.
- Subjects
- *
ANALYSIS of variance , *ARGININE , *DIETARY supplements , *ENZYME-linked immunosorbent assay , *MEN'S health , *NITRATES , *NITRITES , *ORAL drug administration , *RELAXATION for health , *SOMATOMEDIN , *STATISTICS , *DATA analysis , *HUMAN growth hormone , *RANDOMIZED controlled trials , *REPEATED measures design , *BLIND experiment - Abstract
l-arginine (2-amino-5-guanidinovaleric acid) is a conditionally essential amino acid. Intravenous (IV) administration of l-arginine invokes a large metabolic (nitrate/nitrite (NOx)) and hormonal (growth hormone (GH), insulin-like growth factor 1 (IGF-1), and insulin) response; however, research examining oral l-arginine supplementation is conflicting, potentially owing to dose. The purpose of this study was examine a low and high dose of oral l-arginine on blood l-arginine, NOx, GH, IGF-1, and insulin response. Fourteen physically active males (age: 25 ± 5 years; weight: 78.0 ± 8.5 kg; height: 179.4 ± 4.7 cm) volunteered to be in a randomized, double-blind, repeated-measures study. Following an overnight fast, an IV catheter was placed in a forearm vein and a resting blood sample was drawn at ∼0800 hours. Each subject was then provided 1 of 3 treatment conditions (placebo, low (0.075 g·kg-1 of body mass), or high (0.15 g·kg-1 of body mass of l-arginine)). Blood samples were drawn at 30, 60, 90, 120, and 180 min after consumption. l-arginine plasma concentrations significantly increased ( p < 0.001) to a similar level at any time point in both the low- and high-dose conditions; there was no change over time in the placebo condition. There was no significant difference between conditions for NOx, GH, IGF-1, or insulin. Based on these findings, a low dose of l-arginine was just as effective at increasing plasma l-arginine concentrations as a high dose; however, neither dose was able to promote a significant increase in NOx, GH, IGF-1, or insulin at rest. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
26. Individual exercise sessions alter circulating hormones and cytokines in HIV-infected men.
- Author
-
Dudgeon, Wesley David, Phillips, Kenneth Doyle, Durstine, John Larry, Burgess, Stephanie E., Lyerly, George William, Davis, John Mark, and Hand, Gregory Allen
- Subjects
- *
ANTIVIRAL agents , *AEROBIC exercises , *ANALYSIS of variance , *CELL receptors , *CLINICAL trials , *CYTOKINES , *DRUG use testing , *EXERCISE , *EXERCISE physiology , *HIV infections , *HORMONES , *HYDROCORTISONE , *INTERLEUKINS , *MEN'S health , *MUSCLE strength , *MUSCLE strength testing , *NURSING assessment , *RESEARCH funding , *SALIVA , *STATISTICAL sampling , *STATISTICS , *TREADMILL exercise tests , *TUMOR necrosis factors , *DATA analysis , *TREADMILLS , *HUMAN growth hormone , *PRE-tests & post-tests , *REPEATED measures design , *EXERCISE intensity , *BLOOD , *ANALYTICAL chemistry , *STANDARDS , *DRUG therapy - Abstract
Exercise has the potential to impact disease by altering circulating anabolic and catabolic factors. It was the goal of this study to determine how different regimens of low-intensity and moderate-intensity exercise affected circulating levels of these anabolic and catabolic factors in HIV-infected men. Exercise-naive, HIV-infected men, medically cleared for study participation, were randomized into one of the following groups: a moderate-intensity group (MOD, who completed 30 min of moderate-intensity aerobic training followed by 30 min of moderate-intensity resistance training; a low-intensity group (LOW), who completed 60 min of treadmill walking; or a control group (CON), who attended the clinic but participated in no activity. Blood and saliva samples were collected at selected time points before, during, and after each of the 3 required sessions. Compared with baseline, the MOD group (n = 14) had a 135% increase in growth hormone (GH) (p < 0.05) and a 34% decrease in cortisol (CORT) (p < 0.05) at the post time point, a 31% increase in interleukin-6 (IL-6) (p < 0.05) at 30-min post exercise, and a 23% increase in IL-6 (p < 0.05) and a 13% decrease in soluble tumor necrosis factor receptor 2 (sTNFrII) (p < 0.05) at 60-min post exercise. The LOW (n = 11) group had a 3.5% decrease in sTNFrII (<0.05) at 30-min post exercise compared with baseline and a 49% decrease (p < 0.05) in GH at 60-min post exercise. The CON group (n = 13) had a decrease in GH at 30-min (62%, p < 0.05) and 60-min (61%, p < 0.05) post exercise compared with baseline. The increase in GH from baseline to post was greater in the MOD group (p < 0.05) and the decrease in CORT from pre to post was greater in the MOD group (p < 0.05) than in the other groups. These data suggest that individual sessions of both low-intensity and moderate-intensity exercise can alter circulating anabolic and catabolic factors in HIV-infected men. The changes in the MOD group present potential mechanisms for the increases in lean tissue mass seen with resistance exercise training. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
27. Le nanisme psychosocial, une réalité toujours d’actualité – à propos d’un cas
- Author
-
Mariani, A., Chalies, S., Jeandel, C., and Rodière, M.
- Subjects
- *
DWARFISM , *MOTHER-child relationship , *BEHAVIOR disorders in children , *SOCIAL problems , *PITUITARY dwarfism , *MALNUTRITION , *FOLLOW-up studies (Medicine) , *PSYCHOLOGY - Abstract
Summary: Psychosocial dwarfism is a rare condition, but can still be observed. We report the case of a 5-year-old girl seen in our clinic for severe growth retardation that had been evolving for several years. A growth arrest was observed beginning at the age of 3.5years. Initial clinical examination and biological investigations were negative. As the child was hospitalized, serious disturbances in mother-child relations were observed. A significant modification of the child''s behavior was observed when the mother was absent. Following questioning, the mother admitted social problems; the pregnancy had not been desired and this contributed to a lack of attachment between the mother and the child. Psychosocial dwarfism seems to originate from serious disturbances in the mother-child relationship. It seems to be caused by a partial growth hormone deficiency and a frequent context of malnutrition due to food behavior disorders. Family problems need to be taken into account and intensive medical and psychological follow-up is required. Prognosis is good if an early diagnosis is made and followed with a close and prolonged follow-up. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
28. À propos d’un retard de croissance chez une enfant de 8 ans
- Author
-
Jerbi Omezzine, S., Hmida, K., Sfar, M.T., and Hamza, H.A.
- Published
- 2009
- Full Text
- View/download PDF
29. Effect of hyperthermia and physical activity on circulating growth hormone.
- Author
-
Ftaiti, Foued, Jemni, Monem, Kacem, Asma, Zaouali, Monia Ajina, Tabka, Zouhair, Zbidi, Abdelkarim, and Grélot, Laurent
- Subjects
- *
PHYSIOLOGICAL effects of heat , *FEVER , *SOMATOTROPIN , *EXERCISE tests , *REGULATION of secretion , *BLOOD plasma , *MUSCLE metabolism , *PHYSIOLOGY - Abstract
The aim of this study was to differentiate the effects of hyperthermia and physical activity on circulating growth hormone (GH) secretion. Nine healthy volunteer adults performed two 40 min exercise trials and two 50 min passive standing trials. The exercise was performed in either thermo-neutral (N-Ex: air temperature 18 °C, air humidity 40%, and wet bulb globe temperature (WBGT) 17.7 °C) or hot environmental conditions (H-Ex: air temperature 33 °C, air humidity 30%, and WBGT 34.6 °C). The passive exposure trials were also performed in either a comfortable (N-P: air temperature 18 °C, air humidity 40%, and WBGT 17.7 °C) or a hot climatic chamber (H-P: air temperature 40 °C, air humidity 100%, and WBGT 97.1 °C). Plasma GH, plasma volume (PV), tympanic temperature (Tty), and body mass loss (BML) were measured before and after each trial. The decrease in PV was significantly higher during H-Ex and H-P sessions than during N-Ex and N-P sessions. Comparisons showed significantly lower BML in the N-Ex session (1.5% ± 0.3%) than in the H-Ex and H-P sessions (2.1% ± 0.3% and 1.9% ± 0.2%, respectively) (p < 0.001). The rise in Tty was significantly higher during the H-P session (2.9 ± 0.4 °C) (p < 0.001) when compared with the other sessions. Plasma GH concentration increased significantly during all the trials, particularly during the H-Ex session (45 ± 7 ng·mL-1) (p < 0.01). Both exercise and heat exposure, separately, are sufficient to increase significantly the plasma GH concentration, and their combined effect induced a highly synergistic rise in GH. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
30. Les taux sériques de ghréline sont modifiés chez les patients atteints de fibromyalgie, mais pas les taux de GH, d'IGF-1 et d'IGFBP-3
- Author
-
Tander, Berna, Atmaca, Aysegul, Aliyazicioglu, Yuksel, and Canturk, Ferhan
- Abstract
Résumé: Introduction: L''axe hypothalamopituitaire IGF-1 et les taux de ghréline pourraient être modifiés dans la fibromyalgie suite à l''augmentation de somatostatine. L''objectif de cette étude est de comparer l''axe hypothalamopituitaire IGF-1, les concentrations de ghréline et leurs relations chez des femmes préménopausées atteintes de fibromyalgie ou saines. Méthodes: Soixante-quinze femmes (47 fibromyalgiques et 28 femmes saines) ont été incluses dans l''étude. La glycémie, l''hormone de croissance (GH), l''insuline, le peptide-C, l''IGF-1, la protéine de liaison-3 de l''IGF-1 (IGFBP-3) et les taux de ghréline ont été mesurés. Les symptômes dépressifs étaient évalués par le Beck Depression Inventory. L''intensité de la douleur et les troubles du sommeil étaient évalués sur une échelle visuelle analogique. L''activité diurne était évaluée par un questionnaire d''impact de la fibromyalgie. Résultats: Il n''y avait pas de différence significative dans les taux de GH, d''IGF-1, d''IGFBP-3, de glucose, d''insuline et de peptide-C entre les patientes fibromyalgiques et les témoins, alors que les taux de ghréline étaient significativement abaissés chez les patients en comparaison des témoins (p <0,05). Les taux de ghréline n''étaient pas corrélés aux taux de GH, d''IGF-1, d''IGFBP-3, de glucose, d''insuline et de peptide C. Ils étaient en revanche, positivement corrélés avec l''index douleur tender point score la sensibilité et les troubles du sommeil, et négativement corrélés avec les scores d''intensité de la douleur. Conclusion: Nos résultats suggèrent que les faibles taux de ghréline au cours de la fibromyalgie ne sont pas liés aux modifications de l''axe hypothalamopituitaire–IGF-1, mais qu''il existe une relation avec certains symptômes de la fibromyalgie. D''autres études sont nécessaires pour éclairer nos résultats. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
31. Modulation of apolipoprotein A1 and B, adiponectin, ghrelin, and growth hormone concentrations by plant sterols and exercise in previously sedentary humans.
- Author
-
Collins, Melissa, Varady, Krista A., and Jones, Peter J.H.
- Subjects
- *
APOLIPOPROTEINS , *CHOLESTEROL , *PHARMACOLOGY , *STEROLS , *CORONARY disease - Abstract
Plant sterols combined with exercise beneficially alter lipid levels in hypercholesterolemic adults. The effect of this combination therapy on other indicators of coronary heart disease risk, however, has yet to be determined. The objective of this trial was to investigate the effect of plant sterols and exercise, alone and in combination, on levels of apolipoprotein (apo) A1 and B, adiponectin, ghrelin, and growth hormone in previously sedentary hypercholesterolemic adults. In an 8 week, parallel-arm trial, 84 subjects were randomized to 1 of 4 groups: combination, exercise, plant sterols, or control. Body mass decreased by 1.1% (p < 0.01) and 0.9% (p < 0.05) in the combination and exercise group, respectively. Low-density lipoprotein cholesterol levels decreased (p < 0.01) by 0.30 mmol/L in the combination group and by 0.49 mmol/L in the plant sterol group. High-density lipoprotein cholesterol levels increased by 7.5% and 9.5% (p < 0.01) in the combination and exercise groups, respectively. Plant sterols increased (p < 0.05) adiponectin levels by 16%. No change in apoA1, apoB, ghrelin, or growth hormone levels were noted in any intervention group. ApoA1 was correlated with high-density lipoprotein cholesterol (r = 0.33, p = 0.01), whereas apoB was weakly related to low-density lipoprotein cholesterol levels (r = 0.13, p = 0.002). Adiponectin was associated with body mass index (r = –0.10, p = 0.006) and high-density lipoprotein cholesterol (r = 0.17, p = 0.0003). These findings suggest that plant sterols can increase adiponectin levels, thereby possibly reducing the risk of future coronary heart disease. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
32. Varying signals of the effects of natural selection during teleost growth hormone gene evolution.
- Author
-
Ryynänen, Heikki J. and Primmer, Craig R.
- Subjects
- *
SOMATOTROPIN , *FISH genetics , *VERTEBRATES , *MOLECULAR evolution , *PITUITARY hormones - Abstract
The growth hormone (GH) gene of teleost fish exhibits a higher degree of variability compared with other vertebrate groups. However, the different selective constraints at the sequence level are not well understood. In this study, maximum-likelihood (ML) models of codon substitutions were used to investigate Darwinian adaptive evolution of the GH gene in teleost fishes. Complete GH gene sequences of 54 fish species were classified into 4 orders, and the variable nature of GH was examined by determining the dN and dS rate variation and the rates of molecular evolution for each teleost order. The results indicate that although the overall evolution rate for teleost GH is high ((1.15 ± 0.01) × 10–9 substitutions/(aa site·y)) compared with the "slow phases" in mammals ((0.21 to 0.28 ± 0.05) × 10–9), the vital structure of this gene has been retained. While the majority of the amino acid changes appear to be due to relaxation of purifying selection, some positively selected sites were detected in regions with no specifically identified role in protein function. The positively selected regions observed in salmoniformes lineage suggests a possible role for positive selection driving functional divergence in paralogous forms of the GH gene after whole-genome duplication in this lineage. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
33. L'hormone de croissance : un dopant ?
- Author
-
Desvigne, N.
- Subjects
- *
SOMATOTROPIN , *ANABOLIC steroids , *SOMATOMEDIN , *DOPING in sports , *MUSCLE strength - Abstract
Abstract: Aim. – This paper presents a review of the biological mechanisms of action of Growth Hormone and it’s associated effects on physical performance. Current. – Growth Hormone is used as a doping substance (to date hardly detectable) since the 80’s in response to the large progresses made in the detection of anabolic steroids. Growth Hormone has two main effects, both through direct and indirect pathways. Growth Hormone has definite but indirect action on growth through Insulin-Like Growth Hormone-I secretion and a direct action on lipolysis and insulin-resistance. Supplementation in Growth Hormone in order to increase physical performances (increases in muscle strength, muscle mass, endurance...) is efficient in Growth Hormone deficient adults but not in other amyotrophic patients with different pathologies. In the elderly and the endurance and/or strength-trained athlete, studies reported a lack of any positive effect on physical performance associated to multiple negative side effects. However, body composition is positively modified with an increase in lean body mass (extra cellular water + conjunctive tissue) and a decrease in fat mass. Conclusion. – Since no evidence support the beneficial effect of growth hormone on physical performances in healthy subjects, extrapolating the results of scientific studies on doping is hazardous as the environmental conditions surrounding the usage of growth hormone are different. The effect of growth hormone on the reduction of fat mass appears to be the main raison for its use as doping substance. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
34. Effects of growth hormone on leucine absorption, intestinal morphology, and ultrastructure of the goldish intestine.
- Author
-
Walker, R. L., Buret, A. G., Jackson, C. L., Scott, K. G. E., Bajwa, R., and Habibi, H. R.
- Subjects
- *
SOMATOTROPIN , *GOLDFISH , *INTESTINES , *MORPHOLOGY , *LEUCINE - Abstract
The mechanisms whereby exogenous growth hormone modulates intestinal structure and function in fish were investigated. Goldfish (Carassius auratus) were fed commercial flake diet sprayed with recombinant carp growth hormone (cGH) daily for 1 month. Control animals received food sprayed with the vehicle. After 1 month of daily feedings, body mass and length were determined, and animals were sacrificed to study intestinal characteristics. Sections of foregut were removed after determination of total gut length for measurement of leucine uptake, histology, and epithelial ultrastructure. Oral administration of cGH for 1 month resulted in a 40% increase in body mass and an 8% increase in body length above controls. Gut length was 43% greater and the gut length to body length ratio was 32% greater as a result of the cGH treatment. Feeding with cGH also resulted in a significant increase in leucine uptake and increased gut mucosal thickness. Analysis of transmission electron micrographs revealed significant increases in the microvillous height and density and epithelial surface area. The findings indicate that growth hormone added to feed may increase growth in fish, in part by significantly increasing gut length, mucosal thickness, and epithelial brush border surface area, leading to enhanced epithelial absorption. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
35. Evolution of duplicated growth hormone genes in autotetraploid salmonid fishes.
- Author
-
McKay, S. J., Trautner, J., Smith, M. J., Koop, B. F., and Devlin, R. H.
- Subjects
- *
SALMON , *BIOLOGICAL evolution , *SOMATOTROPIN , *GENES , *GENOMES , *FISHES - Abstract
A defining character of the piscine family Salmonidae is autotetraploidy resulting from a genome-doubling event some 25–100 million years ago. Initially, duplicated genes may have undergone concerted evolution and tetrasomic inheritance. Homeologous chromosomes eventually diverged and the resulting reduction in recombination and gene conversion between paralogous genes allowed the re-establishment of disomic inheritance. Among extant salmonine fishes (e.g. salmon, trout, char) the growth hormone (GH) gene is generally represented by two functional paralogs, GH1 and GH2. Sequence analyses of salmonid GH genes from species of subfamilies Coregoninae (whitefish, ciscos) and Salmoninae were used to examine the evolutionary history of the duplicated GH genes. Two divergent GH gene paralogs were also identified in Coregoninae, but they were not assignable to the GH1 and GH2 categories. The average sequence divergence between the coregonine GH genes was more than twofold lower than the corresponding divergence between the salmonine GH1 and GH2. Phylogenetic analysis of the coregonine GH paralogs did not resolve their relationship to the salmonine paralogs. These findings suggest that disomic inheritance of two GH genes was established by different mechanisms in these two subfamilies. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
36. Hypophysis.
- Author
-
Léger, J. and Czernichow, P.
- Subjects
PITUITARY gland ,SOMATOTROPIN ,DEVELOPMENTAL disabilities ,DIAGNOSTIC imaging ,HEREDITY - Abstract
Copyright of EMC-Pediatrie is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2004
- Full Text
- View/download PDF
37. GH, IGF-1 and IGF-BP3 responses to submaximal exercise: differences between trained and sedentary subjects
- Author
-
Mejri, S., Bchir, F., Koubâa, D., and Ben Slama, C.
- Abstract
Aim. – We explored growth hormone (GH), insulin-like growth factor 1 (IGF-1) and IGF-BP3 (IGFs binding protein 3) responses during a submaximal exercise and its recovery in trained and sedentary young subjects.Subjects and methods. – The study investigates 18 year old sportsmen (N = 20) and sedentary boys of the same age as control group (N = 19). A 20 min exercise is performed on an ergocycle to reach by steps 90% of the theoretical maximal heart rate which is maintained during the last 7 min. Blood samples were drawn before the test, at the end of exercise and at 10th, 20th and 45th minutes in the recovery period.Results. – Basal GH levels are higher in sportsmen than in controls (4 ± 5 vs. 2 ± 1 mUI/ml; P < 0.05) and during recovery (P < 0.005). Basal IGF-1 level is lower in sportsmen than in controls (705 ± 232 vs. 357 ± 83 ng/ml; P < 0.0001), at all times during exercise. Basal IGF-BP3 levels are 4.5 ± 1.1 μg/ml in sportsmen and 4.4 ± 1.2 in controls. IGF-PB3 is not modified by exercise and does not depend on the training level. The W170 (power capacity at 170 pulses/min), and the maximal oxygen uptake differ between the two groups (P < 0.0001). Glycaemic variations during the test did not differ significantly between the two groups.Conclusion. – Response of GH to exercise is more significant in sportsmen than in sedentary men; IGF-1 and IGF-BP3 levels do not vary significantly during exercise. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
38. Anabolic Hormones in Aging Women: Effects of Supplementation vs. Physical Activity.
- Author
-
Copeland, Jennifer L.
- Abstract
Copyright of Canadian Journal of Applied Physiology is the property of Canadian Science Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2004
- Full Text
- View/download PDF
39. Arthrites juve´niles et croissance staturoponde´rale
- Author
-
Simon, Dominique and Czernichow, Paul
- Published
- 2003
- Full Text
- View/download PDF
40. La rétinopathie diabétique du sujet jeune: l'enfant et l'adolescent.
- Author
-
Ben Mehidi, A, Massin, P, Guyot-Argenton, C, Erginay, A, Guillausseau, PJ, and Gaudric, A
- Subjects
DIABETIC retinopathy ,DIABETES complications ,RETINAL diseases ,DIABETES in children ,DIABETES in adolescence - Abstract
Copyright of Diabetes & Metabolism is the property of Masson Editeur and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2003
- Full Text
- View/download PDF
41. Physiopathologie de la douleur de la fibromyalgie
- Author
-
Houvenagel, Éric
- Published
- 2003
- Full Text
- View/download PDF
42. About exploration of growth hormone secretion.
- Author
-
Souberbielle, J.-C.
- Subjects
SOMATOTROPIN ,CLINICAL chemistry ,PATHOLOGICAL physiology - Abstract
Copyright of IBS, Immuno-analyse & Biologie Specialisee is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2003
- Full Text
- View/download PDF
43. A mathematical model on the effect of growth hormone on glucose homeostasis
- Author
-
Hannah Al Ali, Merabet Nora, Boutayeb Wiam, Boutayeb Abdesslam, School of Mathematics, Statistics & Computing, Emirates Aviation University, Dubai, UAE, Department of Mathematics, and Université Mohamed 1 Oujda MAROC
- Subjects
Recepteurs d'insuline ,Equilibrium ,medicine.medical_treatment ,[MATH.MATH-DS]Mathematics [math]/Dynamical Systems [math.DS] ,030209 endocrinology & metabolism ,Growth hormone ,Stabilité ,03 medical and health sciences ,Receptor Dynamics ,Insuline ,0302 clinical medicine ,Recpteurs d'insuline ,medicine ,Glucose homeostasis ,Insulin ,MOTS-CLÉS : Modèle ,[MATH]Mathematics [math] ,Receptor ,Hormone de Croissance ,030304 developmental biology ,Cellules beta ,0303 health sciences ,β-Cell Mass ,Free Fatty Acids ,Chemistry ,Hormone de croissance KEYWORDS : Model ,General Medicine ,Glucose ,Acides gras libres ,Growth Hormone ,Biophysics ,Equilibre ,Stability ,Cellules β ,Simulation ,Model - Abstract
Extending an existing model devoted to the interaction between β-Cell Mass, Insulin, Glucose, Receptor Dynamics and Free Fatty Acids in glucose regulatory system simulation, this paper proposes a mathematical model introducing the effect of growth hormone on the glucose homeostasis alongside the other variables. Stability analysis is carried out and pragmatic explanation of the equilibrium points is emphasized. Finally, simulation illustrated how β-Cell Mass, Insulin, Glucose, Receptor Dynamics, Free Fatty Acids and Growth Hormone may vary with different values of some parameters in the model., Prolongeant un précédent model publié dédié à l'interaction entre les cellules beta, l'insuline, le glucose, les recpteurs d'insuline et les acides gras libres, cet article propose un modele mathématique introduisant l'effet de l'hrmone de croissance sur la homéostasie du glucose. L'analyse de stabilité a été suivie d'explication pratique des points d'équilibre. Enfin, la simulation a illustré comment les cellules beta, l'insuline, le glucose, les recpteurs d'insuline, les acides gras libres et l'hormone de croissance peuvent varier en fonction des différentes valeurs de certains paramètres.
- Published
- 2019
44. Analysis of tubulins and growth hormone by mass spectrometry
- Author
-
Dadi, Hala, Laboratoire de Chimie Physique D'Orsay (LCPO), Université Paris-Sud - Paris 11 (UP11)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Université Paris Saclay (COmUE), Antoine Pallandre, and Claire Smadja
- Subjects
Chromatography ,Mass spectrometry ,[SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication ,Chromatographie ,[CHIM.ANAL]Chemical Sciences/Analytical chemistry ,Ion mobility ,Spectrométrie de masse ,Peptides ,Hormone de croissance ,Growth hormone ,Anti-dopage ,Anti-doping ,Mobilité ionique - Abstract
The tubulins are proteins involved in cellular processes that are essential for cell life. The tubulins are polymodified at their C-terminal extremities. Different techniques have been used to characterize the polymodifications of tubulins. However, some challenges remain in the fine identification of some structures. In fact, mass spectrometry ion mobility can separate ions of the same m/z ratio depending on their conformations. In the first part of this thesis, an ion mobility mass spectrometry analysis allowed the separation of two synthetic peptides that mimic the structure of C-terminal peptides of biglycylated α-tubulins. In order to extrapolate this type of experiment to the C-terminal peptides purified from biological tubulins, we employed an analytical process to analyze these peptides from purified brain tubulins. Growth hormone (GH) is an anabolic hormone and a doping agent used by athletes. The availability of rhGH in the black-market has continuously increased because of doping in sports. The natural and the biosynthetic hGH have identical peptidic sequences. So far, the valid hGH anti-doping tests by the world antidoping agency are based on immunological recognition. However, Immunoassays have their own limitations. Therefore, the next generation analysis of GH has to be more specific and accurate. In the second part of this thesis, mass spectrometry coupled to reversed phase chromatography was used to find chemical differences between the pituitary hGH and the rhGH. The pituitary extracted hGH is glycosylated whereas the biotech product is sugar free. The present work represents an opening towards a novel methodology for a novel hGH anti-doping test.; Les tubulines sont des protéines impliquées dans des processus biologiques essentiels à la vie cellulaire. Elles sont polymodifiées en leurs extrémités C-terminales. Différentes techniques ont été utilisées pour caractériser les polymodifications des tubulines. Mais certaines difficultés persistent concernant l’indentification fine de plusieurs structures. Le couplage de spectrométrie de masse à la mobilité ionique représente une avancée technique plus pertinente pour la séparation d’isomères de structures. En effet, la mobilité ionique peut séparer des ions de même rapport m/z en fonction de leur conformation. Dans la première partie de cette thèse, une analyse par mobilité ionique et spectrométrie de masse en tandem a permis la séparation de deux peptides de synthèse mimant des peptides C-terminaux de tubuline α diglycylés. L’hormone de croissance (GH) est une hormone anabolique et un agent dopant pour les sportifs. La disponibilité de la hGH recombinante (rhGH) dans le marché noir a augmenté la fréquence du dopage à la GH. Les tests antidopage approuvés par l’agence mondiale d’antidopage sont confrontés à certaines limites. Dans la deuxième partie de ma thèse, des analyses comparatives de la hGH naturelle et la rhGH ont été réalisées par spectrométrie de masse couplée à la chromatographie liquide en phase inverse pour trouver une différence chimique entre la hGH naturelle et la rhGH. La hGH naturelle extraite des glandes pituitaires de cadavres est glycosylée alors que la rhGH n’est pas modifiée. De manière intéressante, cette glycosylation se trouve sur un peptide protéospécifique de la hGH. Ce travail ouvre une piste pour le développement d’une nouvelle méthodologie pour les tests anti-dopage à la GH.
- Published
- 2018
45. Analyse par spectrométrie de masse des tubulines et de l'hormone de croissance
- Author
-
Dadi, Hala, Laboratoire de Chimie Physique D'Orsay (LCPO), Université Paris-Sud - Paris 11 (UP11)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Université Paris Saclay (COmUE), Antoine Pallandre, and Claire Smadja
- Subjects
Chromatography ,Mass spectrometry ,[SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication ,Chromatographie ,[CHIM.ANAL]Chemical Sciences/Analytical chemistry ,Ion mobility ,Spectrométrie de masse ,Peptides ,Hormone de croissance ,Growth hormone ,Anti-dopage ,Anti-doping ,Mobilité ionique - Abstract
The tubulins are proteins involved in cellular processes that are essential for cell life. The tubulins are polymodified at their C-terminal extremities. Different techniques have been used to characterize the polymodifications of tubulins. However, some challenges remain in the fine identification of some structures. In fact, mass spectrometry ion mobility can separate ions of the same m/z ratio depending on their conformations. In the first part of this thesis, an ion mobility mass spectrometry analysis allowed the separation of two synthetic peptides that mimic the structure of C-terminal peptides of biglycylated α-tubulins. In order to extrapolate this type of experiment to the C-terminal peptides purified from biological tubulins, we employed an analytical process to analyze these peptides from purified brain tubulins. Growth hormone (GH) is an anabolic hormone and a doping agent used by athletes. The availability of rhGH in the black-market has continuously increased because of doping in sports. The natural and the biosynthetic hGH have identical peptidic sequences. So far, the valid hGH anti-doping tests by the world antidoping agency are based on immunological recognition. However, Immunoassays have their own limitations. Therefore, the next generation analysis of GH has to be more specific and accurate. In the second part of this thesis, mass spectrometry coupled to reversed phase chromatography was used to find chemical differences between the pituitary hGH and the rhGH. The pituitary extracted hGH is glycosylated whereas the biotech product is sugar free. The present work represents an opening towards a novel methodology for a novel hGH anti-doping test.; Les tubulines sont des protéines impliquées dans des processus biologiques essentiels à la vie cellulaire. Elles sont polymodifiées en leurs extrémités C-terminales. Différentes techniques ont été utilisées pour caractériser les polymodifications des tubulines. Mais certaines difficultés persistent concernant l’indentification fine de plusieurs structures. Le couplage de spectrométrie de masse à la mobilité ionique représente une avancée technique plus pertinente pour la séparation d’isomères de structures. En effet, la mobilité ionique peut séparer des ions de même rapport m/z en fonction de leur conformation. Dans la première partie de cette thèse, une analyse par mobilité ionique et spectrométrie de masse en tandem a permis la séparation de deux peptides de synthèse mimant des peptides C-terminaux de tubuline α diglycylés. L’hormone de croissance (GH) est une hormone anabolique et un agent dopant pour les sportifs. La disponibilité de la hGH recombinante (rhGH) dans le marché noir a augmenté la fréquence du dopage à la GH. Les tests antidopage approuvés par l’agence mondiale d’antidopage sont confrontés à certaines limites. Dans la deuxième partie de ma thèse, des analyses comparatives de la hGH naturelle et la rhGH ont été réalisées par spectrométrie de masse couplée à la chromatographie liquide en phase inverse pour trouver une différence chimique entre la hGH naturelle et la rhGH. La hGH naturelle extraite des glandes pituitaires de cadavres est glycosylée alors que la rhGH n’est pas modifiée. De manière intéressante, cette glycosylation se trouve sur un peptide protéospécifique de la hGH. Ce travail ouvre une piste pour le développement d’une nouvelle méthodologie pour les tests anti-dopage à la GH.
- Published
- 2018
46. GROWTH HORMONE (GH) AND TRIGLYCERIDE-RICH LIPOPROTEIN (TRL) METABOLISM: EFFECT OF ONE MONTH OF DISCONTINUED GROWTH HORMONE TREATMENT IN GROWTH HORMONE DEFICIENT PATIENTS
- Author
-
René Valéro, A. Calabrese, Marie Maraninchi, E. Wolff, J. Dupont, Sophie Béliard, Alain Nicolay, CH de Roanne, Maladies Métaboliques et Endocrinologie, Université de la Méditerranée - Aix-Marseille 2, Nutrition, obésité et risque thrombotique (NORT), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre recherche en CardioVasculaire et Nutrition (C2VN), and ProdInra, Migration
- Subjects
insulinorésistance ,Triglyceride rich lipoprotein ,medicine.medical_specialty ,[SDV]Life Sciences [q-bio] ,030204 cardiovascular system & hematology ,Growth hormone ,état postprandial ,hormone de croissance ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Food and Nutrition ,triglyceride ,profil lipidique ,030304 developmental biology ,0303 health sciences ,lipoprotéine ,business.industry ,Metabolism ,3. Good health ,Growth hormone treatment ,accident cardiovasculaire ,[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition ,Endocrinology ,Alimentation et Nutrition ,hypertriglyceridemie ,lipids (amino acids, peptides, and proteins) ,Cardiology and Cardiovascular Medicine ,business ,[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition - Abstract
International audience; Aim: Growth hormone (GH) deficiency is associated with increased cardiovascular mortality. Insulin resistant states and lipid profile alterations with hypertriglyceridemia, decreased HDL cholesterol, increased small and dense LDL and postprandial hyperlipidemia are commonly observed in GH deficient patients but GH specific function in triglyceride-rich lipoprotein (TRL) metabolism regulation remains unclear. Methods: Lipids and apolipoproteins (apo) profiles were investigated in fasting and postprandial states in plasma and TRL fractions during a test meal before (M0) and after one month of discontinued GH treatment (M1) in GH deficient patients (n=10). Results: After one month of discontinued GH treatment, GH levels remained unchanged but IGF-1 decreased significantly (-12,12±2,36nmol/L). We observed a significant weight loss (-1,31±0,45kg) together with body composition significant changes : lean mass decrease and fat mass increase (-1,17±0,41kg and +0,36±0,16kg respectively), and insulin resistance parameters modifications with a significant HOMA-index reduction (-0,45±0,19) associated with both significant decreased fasting insulin and C-peptide (-2,04±0,78Mui/L and -0,15±0,05nmol/L respectively) but fasting plasma glucose remained unchanged. Fasting plasma triglycerides and apoC-III levels decreased significantly (-0,41±0,16mmol/L and -23,07±6,93mg/L respectively), main other fasting lipid parameters assessed in the plasma fraction (total, LDL and HDL cholesterol, but also apoA1, apoB, apoB48 and apoC-II) were unchanged. Triglycerides but also apoC-II and apoC-III levels assessed in TRL fraction decreased significantly both in fasting and postprandial states after GH discontinuation. Conclusions: Lipid profiles alterations both in fasting and postprandial states were observed in GH deficient patients after GH treatment discontinuation suggesting a specific role of GH in TRL metabolism specifically altered in this pathology.
- Published
- 2018
- Full Text
- View/download PDF
47. Physiopathologie des formes infectieuses de maladies à prions humaines : étude des formes iatrogènes secondaires à un traitement par l'hormone de croissance
- Author
-
Peckeu, Laurène, Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Université Pierre et Marie Curie - Paris VI, Stéphane Haïk, Dominique Costagliola, and Jean-Philippe Brandel
- Subjects
Iatrogenic Creutzfeldt-Jakob disease ,Physiopathologie ,Human growth hormone ,Souches ,Prions ,[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO] ,Epidémiologie ,Hormone de croissance ,Maladie de Creutzfeldt-Jakob iatrogène - Abstract
Prion diseases are fatal and transmissible neurodegenerative disorders. Infectious forms include iatrogenic Creutzfeldt-Jakob disease after human cadaver-sourced growth hormone treatment (hGH-iCJD). Our understanding of the factors governing the pathophysiology of infection, upon exposure to an exogenous prion, remains very limited in humans. The aim of this study was to better understand these phenomena using data from the French cohort of patients who were exposed to this at risk treatment. Using Cox hazards model, we provided the first epidemiological evidence of a relationship between dose of exposure and disease occurrence on one hand and incubation time on the other hand. Incubation period modelling by Weibull distribution estimated that 95% of the cases have already occurred. In a descriptive study, we showed that clinical and neuropathological features resembled other forms of infectious prion diseases after a peripheral contamination supporting a major role of the route of exposure. We also performed experimental transmission to transgenic mice expressing human PrP to test our hypotheses about the infecting prion strain that were transmitted to French hGH-iCJD patients. To conclude, we identified factors implicated in human prion transmission and provided a methodological frame and useful information that could help to evaluate the transmission risk associated with other brain proteinopathies such as Alzheimer and Parkinson’s diseases for which a prion-like mechanism has been proposed.; Les maladies à prions sont des maladies neurodégénératives et transmissibles. Elles sont à l'origine de formes infectieuses comme la maladie de Creutzfeldt-Jakob iatrogène secondaire à un traitement par hormone de croissance d'origine humaine (MCJ post-hGH). La compréhension des facteurs gouvernant la physiopathologie de ces formes demeure parcellaire. Notre objectif a été de les étudier en analysant la cohorte des patients français exposés à l'hGH. Les analyses épidémiologiques, ont montré, à partir de données quantifiées, pour la première fois chez l'homme, une relation entre la dose d'exposition et le risque de développer la maladie d'une part et la durée de la période d'incubation d'autre part. La modélisation de la période d'incubation, a permis d'estimer que 95% des cas sont déjà apparus et d'évaluer l'influence du polymorphisme au codon 129 du gène codant la protéine prion sur la période d'incubation. L'étude descriptive a montré des similarités clinico-pathologiques entre tous les cas de maladies à prion humaines par contamination périphérique laissant supposer un rôle important de la voie d'exposition. Les expériences de transmission à la souris transgénique devraient permettre de valider les hypothèses que nous avons émises sur l'identité des souches présentes dans les lots contaminés. Ce travail a donc permis de mieux caractériser les facteurs impliqués dans la transmission des maladies à prions chez l'homme et de fournir un cadre méthodologique et des informations qui pourraient être utiles pour évaluer le risque de transmission potentielle des autres protéinopathies du système nerveux central pour lesquelles un mécanisme " prion like " a été proposé.
- Published
- 2017
48. Traitement par hormone de croissance des enfants nés petits pour l'âge gestationnel : la cause de l'hypotrophie est-elle un des facteurs influençant la réponse au traitement ?
- Author
-
Gaspard, Julie, UNIROUEN - UFR Santé (UNIROUEN UFR Santé), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU), and Mireille Castanet
- Subjects
Growth hormone (GH) ,Samll for gestational age (SGA) ,Petit pour l'âge gestationnel ,Hormone de croissance ,Somatropine ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
10% des enfants naissent « petits pour l'âge gestationnel » (SGA) (poids et/ou taille br> Objectif évaluer, selon l'étiologie du SGA, la réponse staturale sous traitement par rh-GH, des enfants nés SGA et restés « petits » ; afin de déterminer si la cause de l'hypotrophie pourrait être un facteur supplémentaire impliqué dans la variabilité de la réponse au traitement. Méthode : Étude rétrospective réalisée aux CHU d'Amiens, Caen et Rouen, incluant les enfants nés SGA, sans déficit en hormone de croissance, restés « petits », traités par rh-GH durant au moins 2 ans en période pré-pubertaire, de 1997 à 2017. Le critère de jugement principal était la vitesse de croissance moyenne annuelle durant les 2 premières années de traitement (VCm). Résultats : Parmi les 113 patients inclus, le SGA était dit de cause vasculaire chez 19, génétique chez 37, environnementale (toxique ou médicamenteuse) chez 13, et restait inconnue chez 44 patients. Le traitement par rh-GH a été débuté à un âge moyen de 6.3 ans (±2.7), à la dose de 0.043 mg/kg/jour (±0.011). La taille moyenne à l'initiation du traitement était de -3.2 DS (±0.8), et atteignait -2.1 DS (±0.7) à 2 ans de traitement. La vitesse de croissance prétraitement était de -1.7 DS (±1.3) ; la VCm sous traitement était de 2 DS (±1.6). L'analyse en sous-groupes a montré que les enfants SGA du fait d'une cause environnementale présentaient une moins bonne réponse au traitement à court terme (p Conclusion : L'étiologie du SGA semble être un facteur pronostic de la réponse au traitement. Cependant, des études à plus large échelle sont nécessaires pour confirmer ces données, afin de mieux définir les conduites thérapeutiques à avoir selon la cause du SGA.
- Published
- 2017
49. Taille finale des déficits somatotropes traités précocement : un modèle thérapeutique
- Author
-
Bensignor, C., De Monléon, J.-V., Polak M, M., Carel, J.-C., and Huet, F.
- Published
- 2009
- Full Text
- View/download PDF
50. Time course alterations of plasma obestatin and growth hormone levels in response to short-term anaerobic exercise training in college women.
- Author
-
Manshouri, Mahnaz, Ghanbari-Niaki, Abbass, Kraemer, Robert R., and Shemshaki, Afsaneh
- Subjects
- *
WOMEN'S health , *SOMATOTROPIN , *ANAEROBIC exercises , *BLOOD plasma , *COLLEGE students , *AMINO acids , *TRAINING - Abstract
Obestatin is a 23-amino-acid peptide encoded by the same gene as ghrelin. Because there is a paucity of data concerning the effects of exercise on obestatin, this study investigated the effect of anaerobic exercise training-detraining on obestatin and growth hormone (GH) plasma levels. Ten young female volunteers participated. Blood was collected 24 h before, and 24 h, 48 h and 7 days after the training. The data indicate that anaerobic training caused a significant reduction in GH levels but had no effect on plasma obestatin concentrations. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.